Growing evidence indicated conflicting results that Interleukin-18 (IL-18) promoter polymorphisms rs1946518 (A-607C), rs187238 (G-137C) and rs549908 (A-105C) were associated with asthma risk. The aim of this study is to comprehensively evaluate the IL-18 polymorphisms and asthma by a systematic review and meta-analysis.
INTRODUCTION
Asthma is a common, complex, chronic medical condition, which is characterized by lung inflammation, involved in regulating the immune response of Th1/Th2 cells. 6 So the IL-18 gene is considered as a candidate asthma susceptibility gene. IL-18 was initially isolated from the serum of Mycobacterium bovis Bacillus Calmette-Guerin (BCG)-infected mice challenged with lipopolysaccharide (LPS) which is a member of the Interleukin-1 (IL-1) family and described as IFN-γ-inducing factor (IGIF). 7, 8 The gene for human IL-18 is located on chromosome 11q22.2-22.3, a region that has been previously linked to atopyrelated traits. 9 Recently, IL-18 promoter polymorphisms at positions A-607C (rs1946518), G-137C (rs187238) and A-105C (rs549908) had been extensively studied. However, the results of these studies were incoherent. Many studied suggested that the IL-18 polymorphisms were associated with asthma, [10] [11] [12] [13] [14] whereas some studies indicated that lack of an association between IL-18 polymorphisms and asthma. 6, [15] [16] [17] [18] The inconsistent results may result in a single study or small sample size makes the lower statistical power. Ma and colleagues' 19 conducted a meta-analysis to evaluate the association between these polymorphisms (A-607C, G-137C) and the risk of asthma in 2012. In their study, A-607C polymorphism was associated with asthma risk, but G-137C did not. In the past few years, more studies concerning the association between the IL-18 polymorphisms (A-607C, G-137C) and the risk of asthma have been published in different regions. 12, 13, 17, 18 We thought these studies should also be included, and we added a new polymorphism (A-105C) of IL-18. 14, 15, 20, 21 Thus, the aim of our study is to use a systematic review and update meta-analysis to estimate the association between IL-18 polymorphisms (A-607C, G-137C, and A-105C) and asthma according to all published case-control studies.
MATERIALS AND METHODS

Publication Search
We searched the PubMed, Medline, Web of Science, Wanfang and China National Knowledge Infrastructure (CNKI) databases for all articles on the association between IL-18 polymorphisms and asthma up till December 30, 2017 . The search terms were as followed: ("IL-18" or "interleukin-18" or "interleukin 18" or "IGIF") and ("genetic variation" or "genetic variant" or "polymorphism" or "snps") and ("asthma" or "bronchial asthma" or "allergic asthma"). All of the identified articles and their references were checked as well for other relevant studies. We evaluated review and previous meta-analysis articles in order to found additional eligible studies.
Inclusion Criteria and Exclusion Criteria
Eligible studies should cater all the followed criteria: 1. Studies on people were associated between the IL-18 gene polymorphisms (A-607C, G-137C, and A-105C) and asthma, but not animal experiments. 2. Studies should cater case-control or cross-sectional research, and excluded review, systematic review or meta-analysis. 3. Data provided within the studies was useful for odds ratios (ORs) and 95% credibility interval (CI), or ORs and 95% CI can be calculated. Studies without extractable or credible data should be excluded. 22 4. For overlapping studies, only the most complete or the latest literature will be included. 5. The meta-analysis is not limited sample size of the literature, no matter how many samples can be included.
Data Extraction
Data was extracted from each eligible literature according to the above-mentioned inclusion and exclusion criteria listed by 2 investigators (Liu H and Zhang W) independently, who were blinded to each other. Extractive data were checked by 1 investigator (Deng XD), and disputed data were resolved through negotiation. Characteristics of the studies were extracted as followed: first author, year of publication, country, Ethnicity, numbers of cases and controls, genotype distribution, allele frequency, evidence of hardy-weinberg equilibrium (HWE), genotyping methods, and matching variables. The basic information of eligible studies was showed in Table 1 .
Quality Score Assessment
Quality of each eligible study was evaluated independently by 3 investigators (Liu H, Zhang W and Liu Y) who were blinded to each other according to a set of predetermined criteria (Supplementary Data) which was modified from previous research, 23, 24 and disputes were settled by consensus among the three authors. Total scores were ranged from 0 (worst) to 10 (best), and quality scores≥6 were identified as highquality studies, whereas as low-quality one (Table 1) . 
Statistical Analysis
We first checked the control subjects in each study if there was significant deviation from the HWE by a web-based program (http://ihg2 helmholtzmuenchen.de/cgi-bin/hw/hwa1.pl), and considered p＜0.05 was significant.
The STATA software (version 12, Stata Corporation) was applied for data calculation and analysis. Summary ORs with corresponding 95% CI were used to estimate the association between genotypes, allele and asthma genetic risk for each polymorphism in different comparison genetic models and allele, including dominant model ( The statistical heterogeneity among eligible studies was estimated using the Q-test and I 2 statistics. 25, 26 The fixed-effect model (Mantel-Haenszel method) was used to estimate the pooled ORs if the heterogeneity among studies was not significant (p>0.10 and I²<50%). Otherwise, random-effect model should be considered. 27, 28 To explore sources of heterogeneity in studies, we used a galbraith plot to estimate the heterogeneity. Besides, logistic meta-regression analysis and subgroup analysis were performed to investigate potential sources of heterogeneity among studies. The logistic meta-regression analysis was conducted by year of publication, ethnicity, sample size (≥500 and＜500 subjects), genotyping methods, matching criteria and HWE. Subgroup analysis included the following variables: ethnicity (Asian and No Asian), Sample size (≥500 and＜500 subjects), genotyping methods (polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) and no PCR-RFLP), matching criteria and quality score. Since the number of studies of -105A/C locus was only 4, logistic meta-regression analysis and subgroup analysis were not performed. Sensitivity analysis was applied to evaluate the reliability of this meta-analysis. A Begg's funnel plot and Egger's regression asymmetry test were used to evaluate publication bias of eligible studies, if p＜0.05, publication bias was considered statistically significant.
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RESULTS
Characteristics of Studies
In total, 12 literatures fulfilled the criteria ( Figure  1 ). 
Main Results of Meta-Analysis
The meta-analysis suggested that the A-607C polymorphism, G-137C polymorphism and A-105C polymorphism were not associated with asthma in all comparison allele and genotypes genetic models (dominant, recessive, heterozygote and homozygote; Table 2 , Table 3 , and Table 4 ). However, we failed to find out any significant association between the A-607C polymorphism, G-137C polymorphism and asthma in all comparison allele and genotypes models through subgroup analysis according to ethnicity, sample size, genotyping methods, matching criteria and quality score ( Table 2, Table 3 ). Since the number of studies of -105A/C locus was only 4, subgroup analysis were not performed. and/or PQ<0.1; otherwise, fixed-effects model was used. NA, not applicable.
Heterogeneity Analysis
A-607C polymorphism
For dominant and heterozygote genetic models, the values of I 2 and P Q were greater than 50% and less than 0.10, which indicated statistically significant heterogeneity among eligible literatures. Logistic metaregression analysis was performed to explore the sources of heterogeneity among the eligible publications, including year of publication, ethnicity, sample size, genotyping methods, matching criteria and HWE. However, no data could explain the heterogeneity in allele and different comparison genetic models (p≥0.501). Subgroup analysis based on ethnicity, sample size, genotyping methods, matching criteria and quality score showed that no asian, PCR-RFLP and small sample size might be the sources of heterogeneity ( 
G-137C Polymorphism
For recessive genetic models, the values of P Q was less than 0.10, which indicated statistically heterogeneity among eligible literatures. Logistic metaregression analysis was performed to explore the sources of heterogeneity among the eligible publications, including year of publication, ethnicity, sample size, genotyping methods, matching criteria. However, no data could explain the heterogeneity in allele and different comparison genetic models (p≥0.728). publication was the major source of the heterogeneity in the meta-analysis.
Sensitivity Analysis
Sensitivity analysis was performed by sequentially deleting one study at a time. For each polymorphism, the significance of pooled ORs were not fundamentally altered under allele and different comparison genetic models (data not shown) that indicated our metaanalysis results were statistically reliable.
Publication Bias
Begg's funnel plot and Egger's test were used to estimate the publication bias. The shapes of the Begg's funnel plot did not indicate any evidence of obvious asymmetry under different genetic models. We did not find obvious publication bias for any of the polymorphisms under different genetic models (A-607C, Egger's test p≥0.806; G-137C, Egger's test p≥0.662; A-105C, Egger's test p≥0.176).
DISCUSSION
I L-18 is a unique cytokine that enhances innate immunity and both Th1 and Th2 driven immune responses. 17 In human beings, the secretion of IL-18 by peripheral blood mononuclear cells and level of serum IL-18 were increased in asthma. 31, 32 So far, the polymorphisms of IL-18 genetic susceptibility to asthma have been widely studied, but the results were not consistent. Therefore, we performed a metaanalysis to clarify the relationship between the three polymorphisms (-607A/C, -137G/C, -105A/C) and susceptibility to asthma.
In current meta-analysis, we did not find a genetic association between the polymorphisms (-607A/C, -137G/C, -105A/C) and asthma risk in overall populations. Interestingly, for -607A/C polymorphism, our result was inconsistent with Ma and colleagues' meta-analysis, 19 it might be that we added three studies which might have effectively altered the overall results. But for -137G/C polymorphism, our result was consistent with Ma and colleagues' meta-analysis 19 , three case-control studies were added, which have no effect on the result. For -105A/C polymorphism, as we have seen, this study was the first comprehensive metaanalysis to evaluate the relationship with asthma susceptibility. Perhaps, the results showed that the three polymorphisms were of no role in asthma risk was premature due to limited number of studies included in this study.
Heterogeneity is a crucial issue when conducting a meta-analysis. There existed significant heterogeneity in dominant and heterozygote genetic models comparisons in A-607C polymorphism. We failed to find any characteristics that could explain the heterogeneity using the meta-regression analysis. Subgroup analysis revealed that no asian, PCR-RFLP and small sample size might be the sources of heterogeneity. The galbraith plots showed that the Lachheb J 10 and Shaaban HH 17 were the outlier studies, which were in accordance with subgroup analysis belong the no asian, PCR-RFLP and small sample size publications. The heterogeneity was greatly dropped under allele and different comparison genetic models by omitting these two literatures, and summary ORs and 95%CI were not significantly influenced. In addition, the results indicated that the study of Lachheb  J   10   and Shaaban HH   17 were the sources of heterogeneity. For -137G/C polymorphism, significant heterogeneity was found in the recessive genetic models. We failed to find any characteristics that could explain the heterogeneity using the meta-regression analysis. Subgroup analysis and galbraith plots showed that the Imboden M 11 maybe the source of heterogeneity. The heterogeneity was greatly dropped under allele and different comparison genetic models by omitting the literature, and summary ORs and 95%CI were not significantly influenced. So, we think the study of Imboden M 11 was the source of heterogeneity. Begg's test and Egger's test showed no publication bias in this meta-analysis, and sensitivity analysis
